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The Ubr1-like canonical N-recognins, widely conserved ubiquitin ligases in eukaryotes, play a role in
the N-end rule pathway-mediated degradation of substrates harboring basic (type-1) or bulky
hydrophobic (type-2) amino acids at the N-terminus. In this study, the roles of conserved domains
were studied in the Schizosaccharomyces pombe Ubr11 protein. Mutations in the UBR box and the
autoinhibitory domain blocked degradation of both type-1 and type-2 substrates, expression of pep-
tide transporter genes, and the uptake of oligopeptides. An N-domain mutant was normal for the
type-1-related function, but nevertheless failed to express peptide transporters. These data suggest
the importance of the type-2-related activity of Ubr11 for its in vivo function.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Proteasome-dependent proteolysis of ubiquitylated substrate
proteins regulates various cellular activities [1]. For ubiquitylation,
ubiquitin ligase recognizes a speciﬁed motif, known as a degron, in
its substrate protein. Ubr family proteins, which are found only in
eukaryotes, are characterized by the presence of a distinctive zinc-
ﬁnger-like UBR box domain. Seven different Ubr proteins in mouse
are classiﬁed into canonical (Ubr1–Ubr3) and non-canonical
groups (Ubr4–Ubr7) by their structure [2–4]. The canonical Ubr
family proteins, which have the RING ﬁnger domain for ubiquitin
ligase activity, together with the UBR box and autoinhibitory do-
main (Supplementary Fig. 1), are widely conserved from yeasts
to mammals. Some, but not all of these canonical Ubr proteins
(typiﬁed by Ubr1 and Ubr2 in mouse, and Ubr1 in Saccharomyces
cerevisiae) are involved in the Arg/N-end rule pathway branch in
the ubiquitin-dependent proteolysis. Details of the N-end rule
pathway have been studied using the N-degron, eK, a 40-residue
Escherichia coli Lac repressor-derived sequence [5]. In the Arg/N-
end rule pathway, the primary determinant of an N-degron is the
presence of either a basic (type-1; Arg, Lys, His) or a bulky hydro-
phobic (type-2; Leu, Ile, Trp, Phe, Tyr) amino acid at the N-termi-
nus [2–6]. A Ubr1-like protein acts as an N-recognin that binds
to the N-terminal residue of the N-degron and ubiquitylates thesubstrate protein before being degraded by the proteasome [2–
4,7,8]. The Ubr1 family N-recognin uses distinct domains to recog-
nize type-1 and type-2 destabilizing N-terminal amino acids. The
UBR box is sufﬁcient for recognition of type-1 residues, whereas
the N-domain, which is structurally similar to the bacterial ClpS
protein, is required for the recognition of type-2 residues [8,9].
The UBR box is conserved among all UBR family proteins, but its
function, especially in the non-N-recognin UBR proteins which
are not involved in the N-end rule pathway, remains unknown.
We investigated the physiological role of two similar, canonical
Ubr1-like proteins, Ubr1 and Ubr11, in Schizosaccharomyces pombe
[10–13]. Although there are pleiotropic defects in the ubr1mutant,
Ubr1 is dispensable for the N-end rule pathway, and only Ubr11
fulﬁlls a role as N-recognin [13,14]. In the absence of Ubr11, cells
fail to transport extracellular oligopeptides because of decreased
mRNA levels for the peptide transporters, Ptr2 and Isp4 [12]. Based
on our results that the C-terminal peptide of the Rec8 meiotic
cohesin subunit is an endogenous substrate of Ubr11, we further
conﬁrmed the speciﬁcity of the N-terminal amino acid for the
N-end rule pathway in S. pombe, in which basic and bulky hydro-
phobic amino acids have potent destabilizing activity, while methi-
onine and alanine were ineffective as other organisms [2–4,13].
Since N-degron sequence was characterized in detail only in the
eK [5,15], we investigated the degradation-inducing sequence
within the Rec8 C-terminal fragment and found that several non-
overlapping regions independently fulﬁll the function as a part of
an N-degron determinant (our unpublished results). However,
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organisms is still unclear. In this study, we tested the functionality
of the eK-derived N-degron, which we termed XaaNd (Supplemen-
tary Fig. 2A), in S. pombe. Further, we examined the roles of the
conserved domains of N-recognin Ubr11, including UBR box, N-do-
main, and autoinhibitory domain whose function is not well
understood. Our results suggest that all of these domains must
be intact for the activation of peptide uptake. Recognition of
type-1 peptides by Ubr11 is insufﬁcient for this purpose. A key
event in the expression of peptide transporter genes is the recogni-
tion of type-2 peptides and/or degradation of type-2 substrate by
Ubr11.
2. Materials and methods
2.1. Yeast strains and culture conditions
The yeast strains used in this study are listed in Supplementary
Table 1. To construct ubr11 mutants, the wild-type ubr11-coding
region with 50- and 30-untranslated regions (791 and 751 bases,
respectively) was obtained by PCR and cloned into the
pCR4Blunt-TOPO vector (Invitrogen). One copy of the Pk epitope
(GIPNPLLGLD) was appended at the N-terminus of the Ubr11 using
inverse PCR, and the following ﬁve mutants (Supplementary Fig. 1)
were generated with this Pk-ubr11+ template plasmid: m1 (Cys126
to Ala, within the UBR box), m2 (Asp150 to Glu, within the UBR
box), m3 (Asp251 to Asn and His254 to Tyr, within the N-domain),
m4 (Cys1339 to Ser, within the RING domain), and m5 (Cys1932 to
Ala and Cys1935 to Ala, within the autoinhibitory domain). After
sequence veriﬁcation, the corresponding ubr11 gene was released
from the vector and used to replace the ubr11:ura4+ allele of the
host S. pombe strain. Colonies exhibiting 5-ﬂuoroorotic acid-resis-
tance were isolated, and correct replacement was conﬁrmed by
PCR. Expression of these mutated ubr11 genes were veriﬁed by
RT-PCR and immunoprecipitation (see below).
Rich complete medium YE5S, and synthetic minimal medium
EMM2, were used for growth in cell culture. These media and other
general yeast methods have been previously described [16]. To ex-
press proteins from the nmt promoter, cells were grown in thia-
mine-free EMM2 for 18–20 h at 30 C. Stability of the N-end rule
substrates (XaaNd–FGFP) was monitored by cycloheximide chase
assay. Cycloheximide was added at 100 lg/ml, simultaneously
with thiamine at 10 lg/ml, to stop expression from the nmt pro-
moter. Dipeptides were purchased from Sigma–Aldrich and Ba-
chem and used at 0.2 mM (to support cell growth) or 5 mM (to
inhibit proteolysis of XaaNd–FGFP).
2.2. Construction of plasmids
Arg–GFP and Met–GFP: The ubiquitin-Xaa–GFP unit was ex-
cised from the corresponding plasmids (Ub-R-GFP or Ub-M-GFP,
obtained from Addgene) [17] by digestion using NheI and XbaI
and inserted in the NheI site of the pDUAL-HFF41 vector [18].
Resultant plasmids were integrated at the leu1–32 locus of the host
S. pombe strain. For S. cerevisiae, plasmids harboring the same Ub-
Xaa–GFP unit in the pYES2 vector [19] were obtained from
Addgene.
XaaNd–FGFP: A variant of eK, the N-terminal 15 amino acids of the
original eK sequence [5], was used. The third and eighth amino acids
were changed to lysines tomimic themutated eKN-degron 119 [15].
The corresponding degron sequence (RHKSGAWKLPVSLVK, denoted
as ArgNd, Supplementary Fig. 2A) was introduced between the ubiq-
uitin and Flag epitopes by inverse PCR to replace the AspRec8c region
with the pDUAL(Ub-AspRec8c-FGFP) template plasmid [13]. As a
result, a GFP-based monitoring substrate protein, denoted as
ArgNd–FGFP, was produced from the resultant plasmid. The codonfor the N-terminal Arg of this N-degron was changed to Met, Trp,
or Leu by site-speciﬁc mutagenesis using inverse PCR. These plas-
mids were integrated at the leu1–32 locus of the host S. pombe
strains.
Ubr11 and Ptr2: The ubr11+-expressing plasmid was previously
described [11]. For the ptr2+ plasmid, the protein-coding region
was ampliﬁed by PCR. The GFP gene was removed from the pDU-
AL-HFG41 vector [18] by cutting with NcoI and BglII, and the
ptr2+ gene was inserted.
2.3. Flow cytometry
To measure relative GFP ﬂuorescence levels, GFP expression
was induced from the nmt promoter in thiamine-free medium at
least for 18 h, in order to attain steady state GFP levels for each
strain. To inhibit degradation via the N-end rule pathway, cells
were treated with 5 mM of dipeptides for the last 3 h. Live cells
were directly analyzed by ﬂow cytometry using FACSCalibur (Bec-
ton Dickinson).
2.4. Immunoprecipitation and immunoblotting
Preparation of total cellular protein extracts and immunoblot-
ting were performed as described previously [11]. For primary
antibodies, anti-GFP (GF200; Nacalai Tesque), anti-PSTAIRE
(Cdc2, sc-53; Santa Cruz Biotechnology), and anti-a-tubulin
(T5168; Sigma–Aldrich) were used. After incubation with horse-
radish peroxidase-conjugated secondary antibody and its chemilu-
minescent substrate, signal was captured by ChemDoc XRS and
quantiﬁed with Quantity One software (Bio-Rad).
To conﬁrm expression of the Pk-tagged Ubr11 proteins from
endogenous promoter, immunoprecipitation and following immu-
noblotting was necessary, possibly due to low expression levels of
the endogenous Ubr11 protein. Cells were lysed in a buffer [50 mM
NaCl, 1 mM EDTA, 50 mM HEPES, pH 7.5, and one protease inhibi-
tor cocktail tablet/10 ml buffer (Roche Diagnostics)] with glass
beads, and extracts were obtained after brief centrifugation
(2300g, 5 min). Two microliters of the monoclonal anti-Pk anti-
body (MCA1360, AbD Serotec) were added to the 15 mg of protein
extracts, which were then rocked for 2 h at 4 C. Dynabeads Protein
G (Invitrogen) were added, and the samples were rocked for an
additional 2 h. Beads were washed three times with the same buf-
fer, resuspended in SDS-sample buffer, and heated for 2 min. Sam-
ples were separated on a 6% polyacrylamide gel, transferred to a
PVDF membrane, and probed with the anti-Pk antibody.
2.5. RNA analysis
Total RNA was prepared and analyzed by reverse transcription-
coupled PCR (RT-PCR), as described previously [11]. RNA was
reverse transcribed to cDNA using a random 9-mer primer, and
the cDNA was then ampliﬁed by PCR with oligonucleotide primers
speciﬁc for peptide transporters (ptr2 and isp4), ubr11, and GFP.
The b-tubulin nda3 was used to ensure the input of equal levels
of RNA for each sample.
3. Results
3.1. Universality of the N-degron sequence
The Arg–GFP (green ﬂuorescent protein) has been used to mon-
itor Arg/N-end rule pathway-dependent degradation in mammals
and S. cerevisiae [17,19]. We compared the ﬂuorescence levels of
this Arg–GFP to that of the stable Met–GFP in S. cerevisiae and in
S. pombe. However, both proteins showed equivalent ﬂuorescence
intensity (Fig. 1Aa) and also comparable GFP protein levels (Fig. 1B,
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construct is not operative in S. pombe. To test the functionality of
another N-degron sequence, a variant of the eK sequence (denoted
here as XaaNd, Supplementary Fig. 2A) was fused to the N-terminus
of the Flag-tagged GFP (FGFP), and its expression level was moni-
tored by ﬂow cytometry. The MetNd–FGFP was highly expressed,
but the ﬂuorescence of ArgNd–FGFP was greatly decreased in a
wild-type strain (Fig. 1Ab). The same ArgNd–FGFP construct was
highly expressed in a ubr11D strain, and a comparable level of
the MetNd–FGFP ﬂuorescence was detected in both wild-type and
ubr11D strains (Supplementary Fig. 2B). We conﬁrmed by immu-
noblotting that the GFP ﬂuorescence levels were completely corre-
lated with the GFP protein levels in each strain (Fig. 1B). When the
N-terminal arginine was changed to another amino acid, TrpNd in-
duced instability only in a wild-type strain, although its effect was
modest compared to ArgNd (Fig. 1B and Supplementary Fig. 2B). In
contrast, LeuNd was not effective in this context (Fig. 1B and Sup-S. cerevisiae S. pombe
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Fig. 1. Functionality of XaaNd N-degron. (A) a. Arg–GFP, previously shown to be an
Arg/N-end rule pathway substrate in other organisms [17,19], was expressed in
yeasts (S. cerevisiae and S. pombe). Its ﬂuorescence levels, which were monitored by
ﬂow cytometry as an indicator of stability, were comparable to those of stable Met–
GFP control, indicating that Arg–GFP was highly expressed in S. pombe unlike in S.
cerevisiae. b. The N-degron ArgNd is functional. Steady state GFP ﬂuorescence levels
in ArgNd- or MetNd-Flag-GFP (FGFP)-expressing wild-type S. pombe cells were
monitored as in a. (B) Expression levels of the degron-fused GFP proteins in S.
pombe. Arg– and Met–GFP proteins in S. pombe (used in Aa, lanes 1 and 2) and
XaaNd–FGFP proteins in wild-type and ubr11D strains (lanes 3–10) were detected by
immunoblotting. a-tubulin levels were used as a loading control. wt; wild-type
strain, D; ubr11D strain (C and D) Ubr11-dependent instability of XaaNd-fused GFP.
Each XaaNd-fused GFP harboring indicated amino acid at the N-terminus was
induced from the thiamine-repressible nmt promoter, then synthesis of XaaNd–GFP
was stopped at 0 min by adding cycloheximide and thiamine. Different amount of
cell extracts were used in wild-type strain samples since expression levels of each
XaaNd–GFP varied: 50 lg for ArgNd–FGFP, 20 lg for TrpNd–FGFP, 2 lg for MetNd– and
LeuNd–FGFP. For ubr11D strain, 2 lg of extracts were used for all samples. Cdc2
levels were monitored as a loading control using 25 lg of extracts for all samples.plementary Fig. 2B), unlike other N-degrons in which leucine
serves as a destabilizing type-2 amino acid [2–4].
Next, the stabilities of the GFP proteins harboring each XaaNd
degron sequence were compared by cycloheximide chase assay.
In wild-type strains showing weak GFP ﬂuorescence, both ArgNd–
and TrpNd–FGFP proteins were unstable (Fig. 1C, lanes 1–4). In
contrast, MetNd– and LeuNd–FGFP were stable over 60 min after the
synthesis of nascent XaaNd–FGFP protein was stopped by cyclohexi-
mide (Fig. 1D). All XaaNd–FGFP were stabilized in ubr11D strains, as
expected (Fig. 1C and D). These results prove that both ArgNd and
TrpNd sequences are functional as a Ubr11-dependent N-degron
in S. pombe. In the following experiments, we used ArgNd- and
TrpNd–FGFP as a type-1 and type-2 model substrate, respectively.
3.2. Role of the conserved domain in Ubr11 protein for the N-end rule
pathway
Thus far, we have used only a ubr11Dmutant that lacks the en-
tire Ubr11 coding region [10–13]. Therefore, ubr11 strains, which
expressed full-length Ubr11 proteins harboring missense mutation
in the conserved domain, were examined. To know the function of
the conserved domains, each mutant had mutation(s) within the
UBR box (possible recognition site for type-1 substrate, ubr11-m1A
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Fig. 2. Degradation of type-1 and type-2 N-end rule substrates by the mutant
Ubr11 protein. (A) Conﬁrmation of the Ubr11 mutant proteins’ expression. Pk-
tagged Ubr11 protein (235 kDa) was precipitated from each strain by anti-Pk
antibody and detected by immunoblotting. Precipitates from non-tagged wild-type
strain were used as control (lane 1). The same extracts from the ubr11-m4 strain
were used for lanes 6 and 8, but the sample in lane 8 was processed without anti-Pk
antibody to serve as another negative control. (B) Functionality of the mutant Ubr11
proteins. ArgNd– (type-1) or TrpNd–FGFP (type-2) was expressed in the indicated
strains, and their GFP protein levels were measured by immunoblotting. (C and D)
Effect of ubr11mutations on the degradation of substrates. Instability of ArgNd– and
TrpNd–FGFP in each ubr11mutant was examined as in Fig. 1. Both type-1 and type-2
substrates were stabilized in Ubr box mutants (ubr11-m1 and -m2). Mutation of the
N-domain (ubr11-m3) hampered the degradation of type-2, but not type-1, N-end
rule substrate. For short-lived samples (C), 40 lg (ArgNd) or 8 lg (TrpNd) of extracts
were used to detect both GFP and Cdc2. For long-lived samples (D), 2 lg and 25 lg
of extracts were used to detect GFP and Cdc2, respectively.
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Fig. 3. Inhibition of Arg/N-end rule pathway-dependent degradation by dipeptides.
(A) Effect of dipeptides on XaaNd–FGFP instability in wild-type strains was
examined as in Fig 1. Before adding cycloheximide and thiamine at 0 min, cells
were pretreated for 15 min with type-1 dipeptide Lys-Leu (+KL, lanes 4–6) or
type-2 dipeptide Tyr-Leu (+YL, lanes 10–12). Control cultures were similarly
processed without adding dipeptides. Quantiﬁcation of the percentage of GFP
protein levels remaining at each time point relative to 0 min is shown in a graph
(bottom). Note that stabilities are shown in logarithmic scale for ArgNd–FGFP but in
linear scale for TrpNd–FGFP. (B) Dipeptides induced accumulation of N-end rule
substrates. XaaNd–FGFP was expressed in the wild-type strain and treated with
water (control) or indicated dipeptide for the last 3 h. GFP protein levels in each
sample were examined by immunoblotting. (C) The wild-type strains expressing
each XaaNd–FGFP were cultured with peptides as in B, and GFP ﬂuorescence levels
were measured by ﬂow cytometry. The type-1 substrate ArgNd–FGFP (gray) was
stabilized by the addition of type-1 dipeptide Lys-Leu (+KL) but not by type-2
dipeptide Tyr-Leu (+YL). In contrast, the same dipeptide Tyr-Leu stabilized the
type-2 substrate TrpNd–FGFP (white). (D) Degradation of ArgNd–FGFP by Ubr11-m3
was not inhibited by the addition of Lys-Leu dipeptide (vector). Effect of the
dipeptide was recovered by a ptr2+-expressing plasmid (gray), as well as a ubr11+-
expressing plasmid (black). (E) Recovery of dipeptide effect in the ubr11-m3 mutant
required ectopic expression of dipeptide transporter Ptr2. Lys-Leu dipeptide
inhibited degradation of ArgNd–FGFP protein and induced its accumulation in
ubr11-m3 mutant only when Ptr2 was expressed from the heterologous nmt
promoter.
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plementary Fig. 1). All ubr11 genes (wild-type and mutants) were
transcribed (Fig. 4B), and expression of the corresponding full-
length protein was conﬁrmed in all mutants (Fig. 2A). Addition of
the Pk epitope did not affect the function of Ubr11 because wild-
type Pk-Ubr11 could induce degradation of both ArgNd–FGFP and
TrpNd–FGFP (Fig. 2B and C). In UBR box mutants (ubr11-m1 and -
m2) harboring a mutation in a putative type-1 amino acid-binding
region, not only the type-1 substrate ArgNd–FGFP but also the type-
2 substrate TrpNd–FGFP unexpectedly accumulated (Fig. 2B) be-
cause of a lack of degradation (Fig. 2D). The mRNA levels for
ArgNd–FGFP were comparable in all strains (Fig. 4B), conﬁrming
that a post-transcriptional step regulated the differences in GFP
protein levels. Accordingly, ﬂuorescence intensity of the ArgNd–
and TrpNd–FGFP in the UBR box mutants was comparable to that
in the ubr11D mutant (Supplementary Fig. 2C), indicating that
Ubr11-m1 and Ubr11-m2 mutant proteins were non-functional
for both type-1 and type-2 substrates.
In contrast, a mutation in the N-domain (ubr11-m3) had differ-
ential effects on the stabilities of the type-1 and type-2 substrates.
Ubr11-m3 did not affect the instability of the ArgNd–FGFP, a type-1
substrate, indicating that this mutation did not interfere with the
function in destabilizing a type-1 substrate (Fig. 2B, C and Supple-
mentary Fig. 2C). However, a type-2 substrate TrpNd–FGFP was
highly expressed in the ubr11-m3 mutant because of its stabiliza-
tion (Fig. 2B, D and Supplementary Fig. 2C). Therefore, ubr11-m3
mutant selectively lost type-2-speciﬁc function but could still rec-
ognize and degrade the type-1 substrate.
Proteolysis of an N-end rule substrate is inhibited by the addi-
tion of dipeptides harboring appropriate N-terminal residues be-
cause the dipeptide and N-degron of a substrate both compete
for the same binding site in the Ubr protein [20]. We were able
to reproduce this in our system: degradation of the ArgNd–FGFP
was slowed in the presence of Lys-Leu, a type-1 dipeptide
(Fig. 3A). Degradation was not completely inhibited by the dipep-
tide, but signiﬁcant levels of ArgNd–FGFP accumulated over 3 h
(Fig. 3B). Similarly, a type-2 dipeptide Tyr-Leu inhibited the degra-
dation of TrpNd–FGFP and induced its accumulation (Fig. 3A and B).
As a result, ﬂuorescence of the ArgNd–FGFP was signiﬁcantly in-
creased after the addition of type-1 dipeptide Lys-Leu but not by
type-2 dipeptide Tyr-Leu (Fig. 3C) or by non-N-end rule dipeptide
Ala-Leu (data not shown). Both arginine and lysine, as an amino
acid monomer, had no such an inhibitory effect (data not shown).
Similarly, TrpNd–FGFP ﬂuorescence increased by the addition of
type-2 dipeptide Tyr-Leu (Fig. 3C), but not by tryptophan or its
methyl ester (data not shown). Another type-2 dipeptide Leu-Ala
showed similar, but only limited activity against TrpNd–FGFP (Sup-
plementary Fig. 2D). These dipeptides had no effect on the GFP lev-
els in the ubr11D mutant (data not shown).
As described, ArgNd–FGFP was unstable in the type-2-speciﬁc
mutant ubr11-m3 (Fig. 2B and C), indicating that type-1 N-degron
normally binds to themutantUbr11-m3protein. Nevertheless, ﬂuo-
rescence intensity of the ArgNd–FGFP in this mutant did not recov-
ered by the addition of type-1 dipeptide Lys-Leu (Fig. 3D, vector).
The defect was completely rescued by the wild-type ubr11+-
expressing plasmid.When the dipeptide transporter, Ptr2, was forc-
edly expressed from the heterologous nmt41 promoter, GFP protein
levels increased in response to the added Lys-Leu (Fig. 3D and E)
without affecting mRNA levels (Supplementary Fig. 2E). These data
support the conclusion that recognition of the type-1 N-degron and
Lys-Leu dipeptide by Ubr11-m3 protein was not abrogated.
3.3. Peptide uptake defect by the ubr11 mutants
To determine why the Lys-Leu dipeptide did not prevent degra-
dation of the ubr11-m3 mutant unless Ptr2 was ectopically pro-vided, utilization of extracellular dipeptides was monitored. In
addition to the three mutants described above (ubr11-m1, -m2,
and -m3), two other strains were constructed (Supplementary
Fig. 1): a mutant in a RING domain (m4) that is generally crucial
for the ubiquitin ligase activity and a mutant in two cysteines
within the C-terminal region (m5) that is proposed to affect the
protein conformation of Ubr1 in S. cerevisiae [21]. Expression of
these mutated genes and corresponding proteins was also con-
ﬁrmed by RT-PCR and immunoblotting (Figs. 2A and 4B). Amount
of Pk-Ubr11-m4 and -m5 proteins may be lower than others, but
this is not conclusive because of the low expression levels of the
endogenous Ubr11 protein (our unpublished results) and difﬁculty
+Lys-Leu +Leucine
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nda3
NC
(wt)
ptr2
isp4
GFP
ubr11
m1 twtw m4 m5m2 m3 Δ
Pk-ubr11
1 2 3 4 5 6 7 8 9
B
Fig. 4. Expression of peptide transporter genes is severely compromised in all ubr11
missense mutants. (A) Dipeptide utilization was abrogated by all missense ubr11
mutations. All strains were auxotrophic for leucine. The type-1 dipeptide Lys-Leu
supported the leucine-dependent growth only for a wild-type strain, but a leucine
monomer supported growth in all strains. Histidine and uracil were added to rescue
their requirement for growth. (B) All missense ubr11 mutants were unable to
induce the expression of peptide transporter genes (ptr2 and isp4). The mRNA levels
were analyzed by RT-PCR. The b-tubulin nda3 gene was used as an internal control
for the input RNA levels. The same mRNAs from Pk-ubr11+ wild-type strain
(KSP2575) were used for lanes 1 and 2, but the sample in lane 1 was processed
without reverse transcriptase as a negative control. Expression of Pk-tagged ubr11
genes was detected in all strains, except ubr11D that lacks most of the coding
region. The GFP mRNA levels were also checked for strains harboring a gene for the
ArgNd–FGFP substrate (lanes 2–6). For lanes 7–9, strains lacking the GFP substrate
gene were used.
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Interestingly, all ﬁve ubr11 mutants failed to utilize dipeptides,
as was previously reported for a ubr11D strain [12], regardless of
whether the dipeptides were type-1 (Lys-Leu, Fig. 4A) or type-2
(Leu-Ala and Tyr-Leu, data not shown). It had been reported that,
in the absence of low amounts of type-1 or type-2 dipeptide, the
non-N-end rule dipeptide Ala-Leu was not effective in supporting
the growth of leucine auxotrophic cells in a certain wild-type
strain of S. cerevisiae [21,22]. In contrast, the same Ala-Leu dipep-
tide was effectively utilized in S. pombe [12], but none of all ﬁve
mutants could use this non-N-end rule dipeptide also (data not
shown).
Previously, we demonstrated that Ubr11 is required for the
expression of transporter genes, ptr2 (for di/tripeptides) and isp4
(for tetra/pentapeptides) [12]. Consistent with the peptide utiliza-
tion defect, the mRNA levels of both ptr2 and isp4 were greatly re-
duced in all ubr11 missense mutants, as well as in the ubr11D
strain (Fig. 4B). The isp4 mRNA levels did not recover by the Lys-
Leu dipeptide uptake in the ubr11-m3 mutant (Supplementary
Fig. 2E). In conclusion, all ﬁve ubr11 mutants are unable to induce
expression of peptide transporter genes, accounting for the peptide
uptake defect in these strains. These data demonstrated the impor-
tance of the type-1 and type2 peptide-recognition sites, and also
suggest a pivotal role of the autoinhibitory domain to positively
support the transcriptional activation of peptide transporter genes.
4. Discussion
In this study,we developed anN-degron, XaaNd, and showed that
XaaNd-fusedGFPwas a useful tool as a convenient reporter substrate
for the study of N-end rule pathway. Both ArgNd and TrpNd induced
degradation of inherently stable GFP, but unexpectedly, LeuNd was
ineffective, unlike the active effect of an N-terminal leucine in theoriginal eK N-degron [5,6]. We previously showed in S. pombe that
an N-terminal leucine stimulated degradation in other N-end rule
substrates (Leu-DHFRts and Leu-Rec8c), though its potency seemed
to be weaker than that of other effective amino acids [13]. Further-
more, the inhibitory action of Leu-Ala on TrpNd–FGFP degradation
was much weaker than that of Tyr-Leu (Supplementary Fig. 2D).
The XaaNd sequence used here lacks C-terminal 25 amino acids in
the original eK degron (Supplementary Fig. 2A), which overlap with
the region required for the efﬁcient degradation of substrates [5].
This truncation and weak nature of the degradation-inducing activ-
ity of leucine may additively reduce the potency of LeuNd.
By using these substrates harboring ArgNd (type-1) or TrpNd
(type-2) N-degron, we investigated the roles of the domains con-
served in canonical Ubr N-recognins. It is known that the UBR box
is sufﬁcient for the recognition of type-1 substrates [8]. The
D176E mutation within the UBR box in S. cerevisiae Ubr1, which
is equivalent to the Ubr11-m2 mutation (D150E) in this study,
was identiﬁed by its type-1 substrate-speciﬁc defect [9]. Indeed,
as seen by the crystal structure, this aspartic acid contacts the a-
amino group of the N-terminal arginine of a substrate (Scc1 pep-
tide) [23]. When aspartic acid in the corresponding position in the
mouse Ubr1 was mutated (D150A), in vitro binding to the type-1
(Arg) peptide was completely inactivated, but the binding to the
type-2 (Phe) peptide was partially affected [8]. Another UBR box
mutant in the mouse Ubr1 (C127A), equivalent to the Ubr11-m1
(C126A) used in this study, also showed no in vitro binding to the
type-1 peptide but residual binding to the type-2 peptide [8]. Un-
like these ﬁndings in other organisms, UBR boxmutants in S. pombe
(Ubr11-m1 and -m2) completely prevented degradation of both
type-1 and type-2 substrates in vivo (Fig. 2B and D). Further,
Cys126, which is mutated in the S. pombe Ubr11-m1, is conserved
in all Ubr proteins including canonical Ubr proteins not functional
as an N-recognin in the Arg/N-end rule pathway (e.g., Ubr1 in S.
pombe [13], Supplementary Fig. 1) and also non-canonical Ubr4–
Ubr7 proteins in mammals [2]. Mutation in the corresponding
cysteine residue in the Arabidopsis BIG protein (Ubr4) leads to the
auxin transport defect [24]. Since this cysteine is critical for coordi-
nating zinc ions in the zinc-ﬁnger-like UBR box in Ubr1 [23], corre-
sponding cysteines play pivotal roles in the formation of a
structural scaffolding for UBR box. Also, regardless of its type-
1-speciﬁc defect in the S. cerevisiaeUbr1-D176Emutant [9], the cor-
responding residue is conserved in all mammalian and S. pombeUbr
proteins, including those irrelevant to the N-end rule pathway
[2,13] (Supplementary Fig. 1). These conserved residues among all
Ubr proteins and their mutants may provide a clue for understand-
ing the function of the UBR box other than the N-end rule pathway.
The only physiological defect in the S. pombe ubr11 mutant
known so far is the unavailability of extracellular peptides [12].
All ﬁve ubr11 mutants examined in this study failed to utilize pep-
tides due to insufﬁcient expression of peptide transporter genes. In
particular, the N-domain mutant protein (Ubr11-m3) is able to
bind type-1 N-degron (ArgNd) and type-1 peptides (Lys-Leu) nor-
mally (Fig. 3D and E), but is unable to utilize dipeptides, irrespec-
tive of whether the peptide is type-1 (Lys-Leu), type-2 (Leu-Ala,
Tyr-Leu), or non-N-end nature (Ala-Leu) (Fig. 4A, data not shown).
It is likely that recognition of type-1 N-degron, or type-1 peptides,
is insufﬁcient for the expression of peptide transporters. Alterna-
tively, the binding of type-1 N-end rule peptide may be uncoupled
from the transcriptional activation of peptide transporter genes in
the ubr11-m3 mutant. In either case, both UBR box and N-domain
must be intact, and degradation of a putative type-2 substrate, or
recognition of type-2 dipeptides itself is indispensable for the
activation of peptide transporter genes.
In S. cerevisiae, peptides accelerate the own uptake through
Ubr1-mediated degradation of Cup9, a repressor of the peptide
transporter expression [21,22]. Cup9 is a substrate of Ubr1, though
K. Kitamura, H. Fujiwara / FEBS Letters 587 (2013) 214–219 219it does not have an N-degron. In the absence of extracellular dipep-
tides, autoinhibitory domain of Ubr1 prevents its recognition of
Cup9, possibly by covering the binding site for Cup9. Upon binding
of dipeptides to the type-1 and type-2 recognition sites in Ubr1,
conformation is switched from closed to open state, which is suit-
able for the recognition and ubiquitylation of Cup9. Consequently,
presence of dipeptides leads to transcriptional activation of the
peptide transporter gene. Interestingly, mutation in the conserved
two cysteines within autoinhibitory domain allows constitutive
binding of Cup9 even in the absence of dipeptides [21]. Since the
role of autoinhibitory domain was evaluated only in S. cerevisiae
Ubr1, we examined the in vivo effects of analogous mutation in S.
pombe (Ubr11-m5), and found that these cysteines were essential
to activate the expression of peptide transporter genes (Fig. 4B).
Further, this mutant protein was unable to degrade both type-1
and type-2 test substrates (Supplementary Fig. 2C). In S. cerevisiae,
the corresponding mutant Ubr1 protein of the autoinhibitory
domain was found to be inactive for rescuing the defect in the
N-end rule pathway in ubr1D cells [21]. Role of the autoinhibitory
domain, other than suppression of needless degradation of sub-
strates, remains to be determined as an important question, since
the autoinhibitory domain and the corresponding cysteines are
also conserved in canonical Ubr proteins including S. pombe Ubr1
which has no role for the regulation of peptide uptake or N-end
rule pathway (Supplementary Fig. 1). Although Ubr ubiquitin ligase
is essential for peptide transporter expression in both S. pombe and
S. cerevisiae, regulation seems to be different between the two
yeasts [12]. In particular, an apparent homolog of Cup9, which is
a target substrate of Ubr1 for peptide utilization in S. cerevisiae,
is not encoded in the S. pombe genome. It is necessary to identify
a possible substrate of Ubr11 as well as a negative and positive reg-
ulatory factors for peptide transporter expression to understand
how Ubr11 regulates transporter expression and how extracellular
peptides affect this regulation.
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